for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zhangzhou Pientzehuang Pharmaceuticl Ltd

600436.SS

Latest Trade

104.94CNY

Change

2.26(+2.20%)

Volume

6,287,128

Today's Range

102.61

 - 

105.54

52 Week Range

71.26

 - 

124.05

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
102.68
Open
102.79
Volume
6,287,128
3M AVG Volume
80.24
Today's High
105.54
Today's Low
102.61
52 Week High
124.05
52 Week Low
71.26
Shares Out (MIL)
603.32
Market Cap (MIL)
59,818.90
Forward P/E
43.12
Dividend (Yield %)
0.61

Latest Developments

More

Zhangzhou Pientzehuang Pharma's H1 Net Profit Up 20.9% Y/Y

Zhangzhou Pientzehuang Pharmaceutical Obtains 51% Stake In Pharma Firm

Zhangzhou Pientzehuang Pharmaceutical To Bid For 51% Stake In Pharma Firm For At Least 165.8 Mln Yuan

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zhangzhou Pientzehuang Pharmaceuticl Ltd

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL.LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension, bupleurum granules for cold, as well as pharmaceuticals for bone injuries and others. The Company is also engaged in the production and distribution of cosmetics and daily use chemicals, such as pearl paste series, sun screen series, anti-spotting series, shampoo, toothpastes and shower gel, among others, and the distribution of food. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

No. 1, Shang Street

+86.596.2306972

http://www.zzpzh.com

Executive Leadership

Jianshun Liu

Chairman of the Board

Haipeng Yang

Chief Accounting Officer

Jinming Huang

General Manager, Director

Jipeng Chen

Deputy General Manager, Secretary of the Board, Director

Jianming Chen

Deputy General Manager

Key Stats

1.53 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

2.3K

2017

3.7K

2018

4.8K

2019(E)

5.9K
EPS (CNY)

2016

0.890

2017

1.340

2018

1.890

2019(E)

2.357
Price To Earnings (TTM)
47.03
Price To Sales (TTM)
11.38
Price To Book (MRQ)
10.17
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
13.80
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
24.48
Return on Equity (TTM)
18.21

Latest News

BRIEF-Zhangzhou Pientzehuang Pharmaceutical passes review of high-tech enterprise recognition

* Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years since 2017

BRIEF-Zhangzhou Pientzehuang Pharma's 9-month net profit up 40.3 pct y/y

Zhangzhou Pientzehuang Pharmaceutical Ltd * Says 9-month net profit up 40.3 percent y/y Source text in Chinese: http://bit.ly/2z9PX5m Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Zhangzhou Pientzehuang Pharmaceutical's preliminary H1 net profit up 41.9 pct y/y

* Says prelim H1 net profit up 41.9 percent y/y at 433.3 million yuan ($64.01 million)

BRIEF-Zhangzhou Pientzehuang Pharma signs strategic agreement with Ping An Bank

Further company coverage: (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up